{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:24:59Z","timestamp":1793330699133,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019832","name":"Gal\u00e1pagos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1136\/ard-2023-224017","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:20:47Z","timestamp":1683120047000},"page":"1049-1058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies"],"prefix":"10.1016","volume":"82","clinical-trial-number":[{"clinical-trial-number":"nct03201445","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03926195","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03201445","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03926195","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Walter","family":"Reinisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radboud J E M","family":"Dolhain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Sikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-3073","authenticated-orcid":false,"given":"Ren\u00e9","family":"Westhovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Seidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Golovchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Simanenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-253X","authenticated-orcid":false,"given":"Olena","family":"Garmish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Jeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Moravcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck-Olivier","family":"Le Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Arterburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-4549","authenticated-orcid":false,"given":"Robin","family":"Besuyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-0104","authenticated-orcid":false,"given":"Dirk","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224017_bib1","author":"European Medicines Agency"},{"key":"10.1136\/ard-2023-224017_bib2","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"10.1136\/ard-2023-224017_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/annrheumdis-2020-219214","article-title":"Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial","volume":"80","author":"Combe","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224017_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.2019.9055","article-title":"Effect of filgotinib vs placebo on clinical response in patients with moderate to severe rheumatoid arthritis refractory to disease-modifying antirheumatic drug therapy: the FINCH 2 randomized clinical trial","volume":"322","author":"Genovese","year":"2019","journal-title":"JAMA"},{"key":"10.1136\/ard-2023-224017_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/annrheumdis-2020-219213","article-title":"Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial","volume":"80","author":"Westhovens","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224017_bib6","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"Feagan","year":"2021","journal-title":"Lancet"},{"key":"10.1136\/ard-2023-224017_bib7","doi-asserted-by":"crossref","first-page":"i019","DOI":"10.1093\/ecco-jcc\/jjab232.017","article-title":"OP18 efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn's disease: results from the phase 2 divergence 2 study","volume":"16","author":"Reinisch","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1136\/ard-2023-224017_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.semarthrit.2020.07.003","article-title":"A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis","volume":"50","author":"De Cock","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-224017_bib9","author":"Food and Drug Administration"},{"key":"10.1136\/ard-2023-224017_bib10","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1007\/s12325-022-02168-4","article-title":"MANTA and MANTA-RAy: rationale and design of trials evaluating effects of filgotinib on semen parameters in patients with inflammatory diseases","volume":"39","author":"Hellstrom","year":"2022","journal-title":"Adv Ther"},{"key":"10.1136\/ard-2023-224017_bib11","author":"European Medicines Agency"},{"key":"10.1136\/ard-2023-224017_bib12","author":"World Health Organization","year":"2010","journal-title":"Laboratory manual for the examination and processing of human semen, 5th ed"},{"key":"10.1136\/ard-2023-224017_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2021.06.016","article-title":"Sertoli cells as key drivers of testis function","volume":"121","author":"O'Donnell","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1136\/ard-2023-224017_bib14","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1715035115","article-title":"Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism","volume":"115","author":"Kristensen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-224017_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2605.1991.tb01071.x","article-title":"Variation of semen quality in normal men","volume":"14","author":"Mallidis","year":"1991","journal-title":"Int J Androl"},{"key":"10.1136\/ard-2023-224017_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.fertnstert.2005.06.048","article-title":"Within- and between-subject variation in semen parameters in infertile men and normal semen donors","volume":"85","author":"Keel","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1136\/ard-2023-224017_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2007.09.046","article-title":"An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study","volume":"53","author":"Hellstrom","year":"2008","journal-title":"Eur Urol"},{"key":"10.1136\/ard-2023-224017_bib18","author":"World Health Organization","year":"1992","journal-title":"Laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 3rd ed"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724423406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724423406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:50:37Z","timestamp":1739505037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724423406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0003496724423406"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224017","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}